A new geopolymeric binder from hydrated-carbonated cement

This paper evaluates the use of hydrated Portland cement as the raw material in the production of geopolymers. The silicon and aluminium oxides needed for the geopolymerization process were produced by the carbonation of hydrated Portland cement, which transforms CSH and CAH (Portland cement hydrates) into silica and alumina gels. Hydrated-carbonated Portland cement was alkali activated with a NaOH/waterglass solution. Pastes and mortars were prepared, and micro-structural and mechanical properties were analyzed. It has been noted that geopolymers are mechanically stable and yield compressive strength higher than 10 MPa when mortars are cured at 65 °C for 3 days. The results have shown that there are interesting possibilities for re-using the cement-rich fraction of construction and demolition waste. Alkaline activation of hydrated-carbonated Portland cement could be considered a low CO 2-emission binder. © 2012 Elsevier B.V. All rights reserved.Paya Bernabeu, JJ.; Borrachero Rosado, MV.; Monzó Balbuena, JM.; Soriano Martinez, L.; Mitsuuchi Tashima, M. (2012). A new geopolymeric binder from hydrated-carbonated cement. Materials Letters. 74:223-225. doi:10.1016/j.matlet.2012.01.132S2232257

New geopolymeric binder based on fluid catalytic cracking catalyst residue (FCC)

This paper provides information about the synthesis and mechanical properties of geopolymers based on fluid catalytic cracking catalyst residue (FCC). FCC was alkali activated with solutions containing different SiO 2/Na 2O ratios. The microstructure and mechanical properties were analysed by using several instrumental techniques. FCC geopolymers are mechanically stable, yielding compressive strength about 68 MPa when mortars are cured at 65°C during 3 days. The results confirm the viability of producing geopolymers based on FCC. © 2012 Elsevier B.V. All rights reserved.We acknowledge the Ministerio de Ciencia e Innovacion (MICINN) of the Spanish Government and FEDER funds (MAT-2011-19934 project) and the PROPG-UNESP "Universidade Estadual Paulista Julio de Mesquita Filho", Brazil.Mitsuuchi Tashima, M.; Akasaki, JL.; Castaldelli, V.; Soriano Martínez, L.; Monzó Balbuena, JM.; Paya Bernabeu, JJ.; Borrachero Rosado, MV. (2012). New geopolymeric binder based on fluid catalytic cracking catalyst residue (FCC). Materials Letters. 80:50-52. https://doi.org/10.1016/j.matlet.2012.04.051S50528

Alkali activated materials based on fluid catalytic cracking catalyst residue (FCC): Influence ofSiO2/Na2O and H2O/FCC ratio on mechanical strength and microstructure

Reuse of industrial and agricultural wastes as supplementary cementitious materials (SCMs) in concrete and mortar productions contribute to sustainable development. In this context, fluid catalytic cracking catalyst residue (spent FCC), a byproduct from the petroleum industry and petrol refineries, have been studied as SCM in blended Portland cement in the last years. Nevertheless, another environmental friendly alternative has been conducted in order to produce alternative binders with low CO2 emissions. The use of aluminosilicate materials in the production of alkali-activated materials (AAMs) is an on going research topic which can present low CO2 emissions associated. Hence, this paper studies some variables that can influence the production of AAM based on spent FCC. Specifically, the influence of SiO2/Na2O molar ratio and the H2O/spent FCC mass ratio on the mechanical strength and microstructure are assessed. Some instrumental techniques, such as SEM, XRD, pH and electrical conductivity measurements, and MIP are performed in order to assess the microstructure of formed alkali-activated binder. Alkali activated mortars with compressive strength up to 80 MPa can be formed after curing for 3 days at 65 C. The research demonstrates the potential of spent FCC to produce alkali-activated cements and the importance of SiO2/Na2O molar ratio and the H2O/spent FCC mass ratio in optimising properties and microstructure.Authors would like to thank to the Ministerio de Ciencia e Innovacion (MICINN) of the Spanish Government (BIA2011-26947) and to FEDER for funding, and also to the PROPG - UNESP "Universidade Estadual Paulista Julio de Mesquita Filho'', Brazil.Mitsuuchi Tashima, M.; Akasaki, JL.; Melges, J.; Soriano Martínez, L.; Monzó Balbuena, JM.; Paya Bernabeu, JJ.; Borrachero Rosado, MV. (2013). Alkali activated materials based on fluid catalytic cracking catalyst residue (FCC): Influence ofSiO2/Na2O and H2O/FCC ratio on mechanical strength and microstructure. Fuel. 108:833-839. https://doi.org/10.1016/j.fuel.2013.02.052S83383910

Effect of curing time on the microstructure and mechanical strength development of alkali activated binders based on vitreous calcium aluminosilicate (VCAS)

The aim of this paper is to study the influence of curing time on the microstructure and mechanical strength development of alkali activated binders based on vitreous calcium aluminosilicate (VCAS). Mechanical strength of alkali activated mortars cured at 65 °C was assessed for different curing times (4¿168 h) using 10 molal NaOH solution as alkaline activator. Compressive strength values around 77 MPa after three days of curing at 65 °C were obtained. 1·68 MPa/h compressive strength gain rate was observed in the first 12 h, decreasing to 0·95 MPa/h for the period of 12¿72 h. The progress of geopolymeric reaction was monitored by means of TGA and, electrical conductivity and pH measurements in an aqueous suspension. Significant decrease in pH and electrical conductivity were observed in the 4¿72 h period, demonstrating the geopolymerization process. Furthermore, SEM images showed an important amount of (N, C)ASH gel and low porosity of the developed matrix.To the Ministerio de Ciencia e Innovacion (MICINN) of the Spanish Government (BIA2011-26947) and also to FEDER for funding and to Vitrominerals company for supplying VCAS samples.Mitsuuchi Tashima, M.; Soriano Martínez, L.; Borrachero Rosado, MV.; Monzó Balbuena, JM.; Paya Bernabeu, JJ. (2013). Effect of curing time on the microstructure and mechanical strength development of alkali activated binders based on vitreous calcium aluminosilicate (VCAS). Bulletin of Materials Science. 36:245-249. https://doi.org/10.1007/s12034-013-0466-zS24524936Bernal S A, Gutiérrez R M, Pedraza A L, Provis J L, Rodriguez E D and Delvasto S 2011 Cem. Concr. Res. 41 1Criado M, Fernández-Jiménez A, Sobrados I, Palomo A and Sanz J 2011 J. Eur. Ceram. Soc. avaiable onlineDavidovits J 2008 Geopolymer chemistry and applications Institute Geopolymere, Saint-Quentin, FranceDuxson P, Fernández-Jiménez A, Provis J L, Lukey G C, Palomo A and van Deventer J S J 2007 J. Mater. Sci. 47 2917Fernández-Jiménez A, Palomo A and Criado M 2005 Cem. Concr. Res. 35 1204Hossain A B, Shrazi S A, Persun J and Neithalath N 2008 J. Transp. Res. Board 2070 32Komnitsas K and Zaharaki D 2007 Miner. Eng. 20 1261Lampris C, Lupo R and Cheeseman C R 2009 Waste Manage. 29 368Lin T, Jia D, Wang M, He P and Liang D 2009 Bull. Mater. Sci. 32 77Lloyd R R, Provis J L and van Deventer J S J 2009 J. Mater. Sci. 44 608Marín-López C, Reyes Araiza J L, Manzano-Ramírez A, Rubio Avalos J C, Perez-Bueno J J, Muñiz-Villareal M S, Ventura-Ramos E and Vorobiev Y 2009 Inorg. Mater. 45 1429Najafi Kani E, Allahverdi A and Provis J L 2012 Cem. Concr. Comp. 34 25Neithalath N, Persun J and Hossain A 2009 Cem. Concr. Res. 39 473Pacheco-Torgal F, Castro-Gomes J and Jalali S 2008a Constr. Build. Mater. 22 1315Pacheco-Torgal F, Castro-Gomex J and Jalali S 2008b Constr. Build. Mater. 22 1201Pacheco-Torgal F, Castro-Gomex J and Jalali S 2008c Constr. Build. Mater. 22 2212Payá J, Borrachero M V, Monzó J, Soriano L and Tashima M M 2012 Mater. Lett. 74 223Puertas F, Martínez-Ramírez S, Alonso S and Vázquez T 2000 Cem. Concr. Res. 30 1625Puertas F, Barba A, Gazulla M F, Gómez M P, Palacios M and Martínez-Ramírez S 2006 Mater. Construc. 56 73Reig L, Tashima M M, Borrachero M V, Monzó J and Payá J 2010 II Simposio aprovechamiento de residuos agro-industriales como fuente sostenible de materiales de construcción p. 83Rodriguez E D, Bernal S A, Provis J, Payá J, Monzó J and Borrachero M V 2012 Cem. Concr. Comp. (submitted)Tashima M M, Borrachero M V, Monzó J, Soriano L and Payá J 2009 COMATCOMP09 p.421Tashima M M, Akasaki J L, Castaldelli V N, Soriano L, Monzó J, Payá J and Borrachero M V 2012 Mater. Lett. 80 50Xu H and van Deventer J S J 2000 Int. J. Miner. Process. 59 247Yao X, Zhang Z, Zhu H and Chen Y 2009 Thermochim. Acta 493 49Zivica V 2004 Bull. Mater. Sci. 27 179Zivica V, Balkovic S and Drabik M 2011 Constr. Build. Mater. 25 220

COVID Isolation Eating Scale (CIES): Analysis of the impact of confinement in eating disorders and obesity-A collaborative international study

Confinement during the COVID-19 pandemic is expected to have a serious and complex impact on the mental health of patients with an eating disorder (ED) and of patients with obesity. The present manuscript has the following aims: (1) to analyse the psychometric properties of the COVID Isolation Eating Scale (CIES), (2) to explore changes that occurred due to confinement in eating symptomatology; and (3) to explore the general acceptation of the use of telemedicine during confinement. The sample comprised 121 participants (87 ED patients and 34 patients with obesity) recruited from six different centres. Confirmatory Factor Analyses (CFA) tested the rational-theoretical structure of the CIES. Adequate goodness-of-fit was obtained for the confirmatory factor analysis, and Cronbach alpha values ranged from good to excellent. Regarding the effects of confinement, positive and negative impacts of the confinement depends of the eating disorder subtype. Patients with anorexia nervosa (AN) and with obesity endorsed a positive response to treatment during confinement, no significant changes were found in bulimia nervosa (BN) patients, whereas Other Specified Feeding or Eating Disorder (OSFED) patients endorsed an increase in eating symptomatology and in psychopathology. Furthermore, AN patients expressed the greatest dissatisfaction and accommodation difficulty with remote therapy when compared with the previously provided face-to-face therapy. The present study provides empirical evidence on the psychometric robustness of the CIES tool and shows that a negative confinement impact was associated with ED subtype, whereas OSFED patients showed the highest impairment in eating symptomatology and in psychopathology.This manuscript and research was supported by grants from the Ministeriode Economía y Competitividad (PSI2015-68701-R), Instituto de Salud Carlos III (ISCIII) (FIS PI14/00290/ INT19/00046nd PI17/01167) and co-funded by FEDER funds/European Regional Development Fund (ERDF), a way to build Europe. CIBERobn, CIBERsam and CIBERDEM are all initiatives of ISCIII. GMB is supported by a postdoctoral grant from FUNCIVA. This initiative is supported by Generalitat de Catalunya. LM is supported by a postdoctoral grant of the mexican institution Consejo Nacional de Ciencia y Tecnología (CONACYT). PPM was supported, in part, by a Portuguese Foundation for Science and Technology grant (POCI-01-0145-FEDER-028145). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript

Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study

Background. The COVID-19 lockdown has had a significant impact on mental health. Patients with eating disorders (ED) have been particularly vulnerable. Aims. (1) To explore changes in eating-related symptoms and general psychopathology during lockdown in patients with an ED from various European and Asian countries; and (2) to assess differences related to diagnostic ED subtypes, age, and geography. Methods. The sample comprised 829 participants, diagnosed with an ED according to DSM-5 criteria from specialized ED units in Europe and Asia. Participants were assessed using the COVID-19 Isolation Scale (CIES). Results. Patients with binge eating disorder (BED) experienced the highest impact on weight and ED symptoms in comparison with other ED subtypes during lockdown, whereas individuals with other specified feeding and eating disorders (OFSED) had greater deterioration in general psychological functioning than subjects with other ED subtypes. Finally, Asian and younger individuals appeared to be more resilient. Conclusions. The psychopathological changes in ED patients during the COVID-19 lockdown varied by cultural context and individual variation in age and ED diagnosis. Clinical services may need to target preventive measures and adapt therapeutic approaches for the most vulnerable patients

Mortality and pulmonary complications in patients undergoing surgery with perioperative sars-cov-2 infection: An international cohort study

Background The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (740%) had emergency surgery and 280 (248%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (261%) patients. 30-day mortality was 238% (268 of 1128). Pulmonary complications occurred in 577 (512%) of 1128 patients; 30-day mortality in these patients was 380% (219 of 577), accounting for 817% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 175 [95% CI 128-240], p<00001), age 70 years or older versus younger than 70 years (230 [165-322], p<00001), American Society of Anesthesiologists grades 3-5 versus grades 1-2 (235 [157-353], p<00001), malignant versus benign or obstetric diagnosis (155 [101-239], p=0046), emergency versus elective surgery (167 [106-263], p=0026), and major versus minor surgery (152 [101-231], p=0047). Interpretation Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research

Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies

Background: Geoeconomic variations in epidemiology, the practice of ventilation, and outcome in invasively ventilated intensive care unit (ICU) patients without acute respiratory distress syndrome (ARDS) remain unexplored. In this analysis we aim to address these gaps using individual patient data of four large observational studies. Methods: In this pooled analysis we harmonised individual patient data from the ERICC, LUNG SAFE, PRoVENT, and PRoVENT-iMiC prospective observational studies, which were conducted from June, 2011, to December, 2018, in 534 ICUs in 54 countries. We used the 2016 World Bank classification to define two geoeconomic regions: middle-income countries (MICs) and high-income countries (HICs). ARDS was defined according to the Berlin criteria. Descriptive statistics were used to compare patients in MICs versus HICs. The primary outcome was the use of low tidal volume ventilation (LTVV) for the first 3 days of mechanical ventilation. Secondary outcomes were key ventilation parameters (tidal volume size, positive end-expiratory pressure, fraction of inspired oxygen, peak pressure, plateau pressure, driving pressure, and respiratory rate), patient characteristics, the risk for and actual development of acute respiratory distress syndrome after the first day of ventilation, duration of ventilation, ICU length of stay, and ICU mortality. Findings: Of the 7608 patients included in the original studies, this analysis included 3852 patients without ARDS, of whom 2345 were from MICs and 1507 were from HICs. Patients in MICs were younger, shorter and with a slightly lower body-mass index, more often had diabetes and active cancer, but less often chronic obstructive pulmonary disease and heart failure than patients from HICs. Sequential organ failure assessment scores were similar in MICs and HICs. Use of LTVV in MICs and HICs was comparable (42\ub74% vs 44\ub72%; absolute difference \u20131\ub769 [\u20139\ub758 to 6\ub711] p=0\ub767; data available in 3174 [82%] of 3852 patients). The median applied positive end expiratory pressure was lower in MICs than in HICs (5 [IQR 5\u20138] vs 6 [5\u20138] cm H2O; p=0\ub70011). ICU mortality was higher in MICs than in HICs (30\ub75% vs 19\ub79%; p=0\ub70004; adjusted effect 16\ub741% [95% CI 9\ub752\u201323\ub752]; p<0\ub70001) and was inversely associated with gross domestic product (adjusted odds ratio for a US$10 000 increase per capita 0\ub780 [95% CI 0\ub775\u20130\ub786]; p<0\ub70001). Interpretation: Despite similar disease severity and ventilation management, ICU mortality in patients without ARDS is higher in MICs than in HICs, with a strong association with country-level economic status. Funding: No funding

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks